EKF
NEUTRALEKF Diagnostics Cancels Treasury Shares
The diagnostics company has cancelled a number of treasury shares and provided an update on its total voting rights.
EKF Diagnostics Holdings
26.75GBX
2.88%
Market Cap
120.13M
Volume
59.51k
17% of avg
P/E Ratio
0.18
EPS (TTM)
1.45
Beta
0.28
Day Range
26.10p - 27.40p
52 Week Range
18.40p26.75p32.90p
26.75p
Upcoming Events
31 December 2025
FY 2025 financial year end
EKF
NEUTRALEKF Diagnostics Announces Change in Shareholding
The healthcare company has announced a change in its shareholder structure.
EKF
NEUTRALEKF Diagnostics Announces Additional Share Buyback Programme
The diagnostics company is launching a new share buyback programme of up to £1.0m.
EKF
GOODEKF Diagnostics Delivers Solid Q1 Trading Update
The diagnostics company reports solid Q1 trading, with adjusted EBITDA performance holding up well despite headwinds. The business is on track to deliver growth for the full year in-line with market expectations.
EKF
NEUTRALEKF Diagnostics Completes Share Buyback Programme
The healthcare diagnostics company has completed its share buyback programme, repurchasing over 4.6 million shares.
EKF
NEUTRALEKF Diagnostics Announces Share Buyback
The healthcare diagnostics company has announced a share buyback program.
EKF
NEUTRALEKF Diagnostics Announces Share Buyback
The healthcare diagnostics company has purchased 200,000 of its own shares at an average price of 21 pence per share.
EKF
NEUTRALEKF Diagnostics Publishes Annual Report and Notice of AGM
The healthcare diagnostics company has published its annual report and notice of upcoming AGM.
EKF
NEUTRALEKF Diagnostics Announces Share Buyback
The healthcare diagnostics company has purchased over 570,000 of its own shares as part of an ongoing buyback program.
EKF
NEUTRALEKF Diagnostics Directors Increase Shareholdings
The healthcare diagnostics company's directors have purchased additional shares in the business.